The Veterinary Medicines (Amendment etc.) Regulations 2024

Amendment to paragraph 22

This section has no associated Explanatory Memorandum

43.  In paragraph 22 (grant of marketing authorisation)—

(a)the existing text is renumbered as sub-paragraph (2);

(b)above that text insert—

22.(1) The Secretary of State must, before granting a marketing authorisation—

(a)verify that the data submitted complies with the requirements set out in these Regulations;

(b)assess the application and data submitted in respect of the veterinary medicinal product; and

(c)reach a conclusion in relation to the benefit-risk balance of granting a marketing authorisation in respect of the veterinary medicinal product..

(c)below the existing text (renumbered as sub-paragraph (2)) insert—

(3) The Secretary of State must set out any terms and conditions in connection with placing the product on the market when granting a marketing authorisation.

(4) Where the marketing authorisation relates to a veterinary medicinal product that contains an antimicrobial the Secretary of State may require the holder of the marketing authorisation to conduct post-authorisation studies in order to ensure that the benefit-risk balance remains positive in relation to the development of antimicrobial resistance..